The Era of Accelerator-based BNCT

Discover the Potential Value and Differentiation of BNCT

The field of oncology is facing increasing cancer rates and pressure in improving quality outcomes while minimizing costs. BNCT is a unique radiation
therapy modality that uses targeted boron-10 drug in combination with a neutron beam to destroy cancer from the inside out in only 1 or 2 sessions.

Learn about the new era in accelerator-based BNCT and the benefits and differentiation this treatment provides in treating difficult and lethal cancers.

First Name (required)

Last Name (required)

Email (required)

Job Title (required)

Medical Role

Company (required)

Address (required)

City (required)

Zip Code (required)

Country (required)

Would you like to be contacted by TAE Life Sciences representative?
YesNo

Comments

European Union’s General Data Protection Regulations (GDPR)

We value privacy and transparency. In order for TAE Life Sciences to continue sending you emails with the latest information about our products and services as well as industry and other marketing materials, we require your consent in accordance with the European Union’s General Data Protection Regulation (GDPR) law that will come into effect on May 25, 2018. If you consent to receive/continue receiving such information from Accuracy and its Affiliates as well as the use of your personal data for such purposes, please click the box above.

Yes, I agree (only required if you are a EU citizen)